Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

Phase II clinical trial of second-line weekly paclitaxel plus trastuzumab for patients with HER2-positive metastatic gastric cancer.

Horita Y, Nishino M, Sugimoto S, Kida A, Mizukami A, Yano M, Arihara F, Matsuda K, Matsuda M, Sakai A.

Anticancer Drugs. 2018 Aug 17. doi: 10.1097/CAD.0000000000000691. [Epub ahead of print]

PMID:
30124494
2.

Undifferentiated pleomorphic sarcoma in a patient with Cowden syndrome after radiotherapy for breast cancer.

Hatta N, Horita Y.

J Dermatol. 2018 Jul 26. doi: 10.1111/1346-8138.14584. [Epub ahead of print] No abstract available.

PMID:
30047560
3.

HMGA1a Induces Alternative Splicing of the Estrogen Receptor-αlpha Gene by Trapping U1 snRNP to an Upstream Pseudo-5' Splice Site.

Ohe K, Miyajima S, Tanaka T, Hamaguchi Y, Harada Y, Horita Y, Beppu Y, Ito F, Yamasaki T, Terai H, Mori M, Murata Y, Tanabe M, Abe I, Ashida K, Kobayashi K, Enjoji M, Nomiyama T, Yanase T, Harada N, Utsumi T, Mayeda A.

Front Mol Biosci. 2018 Jun 8;5:52. doi: 10.3389/fmolb.2018.00052. eCollection 2018.

4.

Evaluation of the Adequacy of WHO Revised Dosages of the First-Line Antituberculosis Drugs in Children with Tuberculosis Using Population Pharmacokinetic Modeling and Simulations.

Horita Y, Alsultan A, Kwara A, Antwi S, Enimil A, Ortsin A, Dompreh A, Yang H, Wiesner L, Peloquin CA.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00008-18. doi: 10.1128/AAC.00008-18. Print 2018 Sep.

PMID:
29914960
5.

Nationwide Multicenter Observational Study of FOLFIRINOX Chemotherapy in 399 Patients With Unresectable or Recurrent Pancreatic Cancer in Japan.

Todaka A, Mizuno N, Ozaka M, Ueno H, Kobayashi S, Uesugi K, Kobayashi N, Hayashi H, Sudo K, Okano N, Horita Y, Kamei K, Yukisawa S, Nakamori S, Yachi Y, Henmi T, Kobayashi M, Boku N, Mori K, Fukutomi A.

Pancreas. 2018 May/Jun;47(5):631-636. doi: 10.1097/MPA.0000000000001049.

PMID:
29683973
6.

HMGA1a induces alternative splicing of estrogen receptor alpha in MCF-7 human breast cancer cells.

Ohe K, Miyajima S, Abe I, Tanaka T, Hamaguchi Y, Harada Y, Horita Y, Beppu Y, Ito F, Yamasaki T, Terai H, Mori M, Murata Y, Tanabe M, Ashida K, Kobayashi K, Enjoji M, Yanase T, Harada N, Utsumi T, Mayeda A.

J Steroid Biochem Mol Biol. 2018 Sep;182:21-26. doi: 10.1016/j.jsbmb.2018.04.007. Epub 2018 Apr 17.

PMID:
29678492
7.

Percutaneous transluminal angioplasty for central venous stenosis or occlusion in hemodialysis patients.

Horita Y.

J Vasc Access. 2018 Mar 1:1129729817747545. doi: 10.1177/1129729817747545. [Epub ahead of print]

PMID:
29529914
8.

Impact of stent deformity induced by the kissing balloon technique for bifurcating lesions on in-stent restenosis after coronary intervention.

Gamou T, Sakata K, Terai H, Horita Y, Ikeda M, Namura M, Yamagishi M, Kawashiri MA.

J Interv Cardiol. 2018 Aug;31(4):421-429. doi: 10.1111/joic.12504. Epub 2018 Mar 6.

PMID:
29510464
9.

Paradoxical impact of decreased low-density lipoprotein cholesterol level at baseline on the long-term prognosis in patients with acute coronary syndrome.

Nakahashi T, Tada H, Sakata K, Yakuta Y, Tanaka Y, Nomura A, Gamou T, Terai H, Horita Y, Ikeda M, Namura M, Takamura M, Hayashi K, Yamagishi M, Kawashiri MA.

Heart Vessels. 2018 Jul;33(7):695-705. doi: 10.1007/s00380-017-1111-3. Epub 2017 Dec 29.

PMID:
29288404
10.

A Prospective, Multicenter Phase II Study of the Efficacy and Feasibility of 15-minute Panitumumab Infusion Plus Irinotecan for Oxaliplatin- and Irinotecan-refractory, KRAS Wild-type Metastatic Colorectal Cancer (Short Infusion of Panitumumab Trial).

Akiyoshi K, Hamaguchi T, Yoshimura K, Takahashi N, Honma Y, Iwasa S, Takashima A, Kato K, Yamada Y, Onodera H, Takeshita S, Yasui H, Sakai G, Akatsuka S, Ogawa K, Horita Y, Nagai Y, Shimada Y.

Clin Colorectal Cancer. 2018 Mar;17(1):e83-e89. doi: 10.1016/j.clcc.2017.10.004. Epub 2017 Oct 16.

PMID:
29169974
11.

Initial and late efficacy of everolimus-eluting stents for small and non-small coronary lesions from evaluating delayed late loss study.

Tama N, Uzui H, Horita Y, Namura M, Tada H.

Heart Vessels. 2017 Dec;32(12):1415-1423. doi: 10.1007/s00380-017-1018-z. Epub 2017 Jul 7.

PMID:
28687988
12.

Gastric adenocarcinoma of the fundic gland (chief cell-predominant type): A review of endoscopic and clinicopathological features.

Miyazawa M, Matsuda M, Yano M, Hara Y, Arihara F, Horita Y, Matsuda K, Sakai A, Noda Y.

World J Gastroenterol. 2016 Dec 28;22(48):10523-10531. doi: 10.3748/wjg.v22.i48.10523. Review.

13.

Reinforcement learning accounts for moody conditional cooperation behavior: experimental results.

Horita Y, Takezawa M, Inukai K, Kita T, Masuda N.

Sci Rep. 2017 Jan 10;7:39275. doi: 10.1038/srep39275.

14.

Impact of Baseline Angiographic Complexities Determined by Coronary Artery Bypass Grafting SYNTAX Score on the Prediction of Outcome After Percutaneous Coronary Intervention.

Nakahashi T, Sakata K, Nomura A, Yakuta Y, Gamou T, Terai H, Horita Y, Ikeda M, Namura M, Takamura M, Kawashiri MA, Yamagishi M, Hayashi K.

Am J Cardiol. 2016 Oct 1;118(7):974-9. doi: 10.1016/j.amjcard.2016.07.009. Epub 2016 Jul 18.

PMID:
27521219
15.

Reinforcement Learning Explains Conditional Cooperation and Its Moody Cousin.

Ezaki T, Horita Y, Takezawa M, Masuda N.

PLoS Comput Biol. 2016 Jul 20;12(7):e1005034. doi: 10.1371/journal.pcbi.1005034. eCollection 2016 Jul.

16.

Molecular Biomarker Study in a Randomised Phase III Trial of Irinotecan Plus S-1 versus S-1 for Advanced Gastric Cancer (GC0301/TOP-002).

Tsuburaya A, Sugimoto N, Imamura H, Nishikawa K, Imamoto H, Tsujinaka T, Esaki T, Horita Y, Kimura Y, Fujiya T, Takayama O, Oono R, Yabusaki H, Taguri M, Morita S, Yamada Y, Tan P, Ninomiya M, Furukawa H, Sasako M.

Clin Oncol (R Coll Radiol). 2016 Aug;28(8):e45-51. doi: 10.1016/j.clon.2016.04.001. Epub 2016 Apr 30.

PMID:
27142170
17.

Transient nature of cooperation by pay-it-forward reciprocity.

Horita Y, Takezawa M, Kinjo T, Nakawake Y, Masuda N.

Sci Rep. 2016 Jan 20;6:19471. doi: 10.1038/srep19471.

18.

Gastric adenocarcinoma of fundic gland type: Five cases treated with endoscopic resection.

Miyazawa M, Matsuda M, Yano M, Hara Y, Arihara F, Horita Y, Matsuda K, Sakai A, Noda Y.

World J Gastroenterol. 2015 Jul 14;21(26):8208-14. doi: 10.3748/wjg.v21.i26.8208.

19.

Cerebral aneurysms associated with segmental dilative arteriopathy of the circle of Willis.

Horita Y, Mikami T, Houkin K, Mikuni N.

Surg Neurol Int. 2015 Jun 25;6(Suppl 9):S291-4. doi: 10.4103/2152-7806.159372. eCollection 2015.

20.

[Effects of workers' interpersonal helping behavior enhancement program].

Horita Y, Otsuka Y.

Sangyo Eiseigaku Zasshi. 2015;57(5):219-29. doi: 10.1539/sangyoeisei.B15001. Epub 2015 Jul 7. Japanese.

21.

Radical removal of recurrent malignant meningeal tumors of the cavernous sinus in combination with high-flow bypass.

Wanibuchi M, Akiyama Y, Mikami T, Iihoshi S, Miyata K, Horita Y, Sugino T, Komatsu K, Suzuki K, Yamashita K, Mikuni N.

World Neurosurg. 2015 Apr;83(4):424-30. doi: 10.1016/j.wneu.2015.01.019. Epub 2015 Feb 3.

PMID:
25655689
22.

[Relationships between workers' interpersonal helping behavior, social supports, job stressors, psychological stress responses, and vigor in manufacturing industry].

Horita Y, Otsuka Y.

Sangyo Eiseigaku Zasshi. 2014;56(6):259-67. doi: 10.1539/sangyoeisei.B14007. Epub 2014 Sep 19. Japanese.

23.

In vitro susceptibility of Mycobacterium tuberculosis isolates to an oral carbapenem alone or in combination with β-lactamase inhibitors.

Horita Y, Maeda S, Kazumi Y, Doi N.

Antimicrob Agents Chemother. 2014 Nov;58(11):7010-4. doi: 10.1128/AAC.03539-14. Epub 2014 Sep 15.

24.

Rigid endoscopic resection of deep-seated or intraventricular brain tumors.

Akiyama Y, Wanibuchi M, Mikami T, Horita Y, Komatsu K, Suzuki K, Otaki S, Mikuni N.

Neurol Res. 2015 Mar;37(3):278-82. doi: 10.1179/1743132814Y.0000000439. Epub 2014 Sep 10.

PMID:
25204627
25.

Biomarkers of reactive resistance and early disease progression during chemotherapy plus bevacizumab treatment for colorectal carcinoma.

Hayashi H, Arao T, Matsumoto K, Kimura H, Togashi Y, Hirashima Y, Horita Y, Iwasa S, Okita NT, Honma Y, Takashima A, Kato K, Hamaguchi T, Shimada Y, Nakagawa K, Nishio K, Yamada Y.

Oncotarget. 2014 May 15;5(9):2588-95.

26.

Comparative study of the effects of antituberculosis drugs and antiretroviral drugs on cytochrome P450 3A4 and P-glycoprotein.

Horita Y, Doi N.

Antimicrob Agents Chemother. 2014 Jun;58(6):3168-76. doi: 10.1128/AAC.02278-13. Epub 2014 Mar 24.

27.

[A case of hepatic sarcoidosis presenting with cirrhotic symptoms].

Kaji K, Ogino H, Hirai S, Shimatani A, Horita Y, Matsuda K, Hiramatsu K, Matsuda M, Shimizu K, Nakanishi Y, Noda Y.

Nihon Shokakibyo Gakkai Zasshi. 2014 Mar;111(3):557-65. Japanese.

PMID:
24598101
28.

Repeated occurrence of slow flow phenomenon during and late after sirolimus-eluting stent implantation.

Sakata K, Namura M, Takagi T, Tama N, Inoki I, Terai H, Horita Y, Ikeda M, Yamagishi M.

Heart Vessels. 2015 May;30(3):406-9. doi: 10.1007/s00380-014-0477-8. Epub 2014 Jan 30.

PMID:
24477746
29.

[Effect of consensus on punitive behavior].

Hatano A, Horita Y, Yamagishi T.

Shinrigaku Kenkyu. 2013 Feb;83(6):582-8. Japanese.

PMID:
23534266
30.

Rejection of unfair offers in the ultimatum game is no evidence of strong reciprocity.

Yamagishi T, Horita Y, Mifune N, Hashimoto H, Li Y, Shinada M, Miura A, Inukai K, Takagishi H, Simunovic D.

Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20364-8. doi: 10.1073/pnas.1212126109. Epub 2012 Nov 27.

31.

Anomalous reactivity of silylborane: transition-metal-free boryl substitution of aryl, alkenyl, and alkyl halides with silylborane/alkoxy base systems.

Yamamoto E, Izumi K, Horita Y, Ito H.

J Am Chem Soc. 2012 Dec 12;134(49):19997-20000. doi: 10.1021/ja309578k. Epub 2012 Nov 29.

PMID:
23171366
33.

A pedunculated polyp-shaped small-bowel lymphangioma causing gastrointestinal bleeding and treated by double-balloon enteroscopy.

Kida A, Matsuda K, Hirai S, Shimatani A, Horita Y, Hiramatsu K, Matsuda M, Ogino H, Ishizawa S, Noda Y.

World J Gastroenterol. 2012 Sep 14;18(34):4798-800.

34.

Mesenteric phlebosclerosis associated with long-term oral intake of geniposide, an ingredient of herbal medicine.

Hiramatsu K, Sakata H, Horita Y, Orita N, Kida A, Mizukami A, Miyazawa M, Hirai S, Shimatani A, Matsuda K, Matsuda M, Ogino H, Fujinaga H, Terada I, Shimizu K, Uchiyama A, Ishizawa S, Abo H, Demachi H, Noda Y.

Aliment Pharmacol Ther. 2012 Sep;36(6):575-86. doi: 10.1111/j.1365-2036.2012.05221.x. Epub 2012 Jul 23.

35.

Potassium tert-butoxide-mediated regioselective silaboration of aromatic alkenes.

Ito H, Horita Y, Yamamoto E.

Chem Commun (Camb). 2012 Aug 18;48(64):8006-8. doi: 10.1039/c2cc32778c. Epub 2012 Jul 6.

PMID:
22772394
36.

[A case of hepatocellular carcinoma showed the usefulness of endoscopic ultrasound-guided fine needle aspiration cytology using the cell block technique for differential diagnosis of gastric submucosal tumor].

Kida A, Matsuda K, Hirai S, Shimatani A, Horita Y, Hiramatsu K, Matsuda M, Ogino H, Shimizu K, Ishizawa S, Noda Y.

Nihon Shokakibyo Gakkai Zasshi. 2012 Jun;109(6):952-60. Japanese.

PMID:
22688172
37.

Antitubercular activity of disulfiram, an antialcoholism drug, against multidrug- and extensively drug-resistant Mycobacterium tuberculosis isolates.

Horita Y, Takii T, Yagi T, Ogawa K, Fujiwara N, Inagaki E, Kremer L, Sato Y, Kuroishi R, Lee Y, Makino T, Mizukami H, Hasegawa T, Yamamoto R, Onozaki K.

Antimicrob Agents Chemother. 2012 Aug;56(8):4140-5. doi: 10.1128/AAC.06445-11. Epub 2012 May 21.

38.

Phase II clinical trial of second-line FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer: AVASIRI trial.

Horita Y, Yamada Y, Kato K, Hirashima Y, Akiyoshi K, Nagashima K, Nakajima T, Hamaguchi T, Shimada Y.

Int J Clin Oncol. 2012 Dec;17(6):604-9. doi: 10.1007/s10147-011-0331-2. Epub 2011 Oct 15.

PMID:
22002492
39.

Pharmacokinetic parameters from 3-Tesla DCE-MRI as surrogate biomarkers of antitumor effects of bevacizumab plus FOLFIRI in colorectal cancer with liver metastasis.

Hirashima Y, Yamada Y, Tateishi U, Kato K, Miyake M, Horita Y, Akiyoshi K, Takashima A, Okita N, Takahari D, Nakajima T, Hamaguchi T, Shimada Y, Shirao K.

Int J Cancer. 2012 May 15;130(10):2359-65. doi: 10.1002/ijc.26282. Epub 2011 Nov 28.

40.

Which DES is the most appropriate for very small target vessels? Experimental study of stent expandable performance with SES, PES, ZES and EES.

Horita Y, Namura M, Ikeda M, Tsuchiya T, Terai H, Fukuoka R, Tama N, Takagi T.

Cardiovasc Interv Ther. 2011 May;26(2):124-30. doi: 10.1007/s12928-011-0053-4. Epub 2011 Feb 18.

PMID:
24122533
41.

Copper(I)-catalyzed regioselective monoborylation of 1,3-enynes with an internal triple bond: selective synthesis of 1,3-dienylboronates and 3-alkynylboronates.

Sasaki Y, Horita Y, Zhong C, Sawamura M, Ito H.

Angew Chem Int Ed Engl. 2011 Mar 14;50(12):2778-82. doi: 10.1002/anie.201007182. Epub 2011 Feb 24. No abstract available.

PMID:
21387486
42.

Serial cardiac influence of volume overload induced by interventional therapy for central venous stenosis or occlusion in chronic hemodialysis patients.

Horita Y, Namura M, Ikeda M, Tsuchiya T, Terai H, Fukuoka R, Tama N, Takagi T, Kumatani Y, Ishimori Y.

J Cardiol. 2011 May;57(3):316-24. doi: 10.1016/j.jjcc.2011.01.004. Epub 2011 Feb 18.

43.

Synthesis and evaluation of anti-tubercular activity of new dithiocarbamate sugar derivatives.

Horita Y, Takii T, Kuroishi R, Chiba T, Ogawa K, Kremer L, Sato Y, Lee Y, Hasegawa T, Onozaki K.

Bioorg Med Chem Lett. 2011 Feb 1;21(3):899-903. doi: 10.1016/j.bmcl.2010.12.084. Epub 2010 Dec 22.

PMID:
21232949
44.

Salivary alpha-amylase levels and big five personality factors in adults.

Inukai K, Shinada M, Tanida S, Takahashi C, Mifune N, Takagishi H, Horita Y, Hashimoto H, Yokota K, Kameda T, Yamagishi T, Takahashi T.

Neuro Endocrinol Lett. 2010;31(6):771-4.

PMID:
21196913
45.

Salivary testosterone levels and autism-spectrum quotient in adults.

Takagishi H, Takahashi T, Yamagishi T, Shinada M, Inukai K, Tanida S, Mifune N, Horita Y, Hashimoto H, Yang Y, Kameda T.

Neuro Endocrinol Lett. 2010;31(6):837-41.

PMID:
21196912
46.

Stress hormones predict hyperbolic time-discount rates six months later in adults.

Takahashi T, Shinada M, Inukai K, Tanida S, Takahashi C, Mifune N, Takagishi H, Horita Y, Hashimoto H, Yokota K, Kameda T, Yamagishi T.

Neuro Endocrinol Lett. 2010;31(5):616-21.

PMID:
21178944
47.

Effectiveness of BCG vaccination to aged mice.

Ito T, Takii T, Maruyama M, Hayashi D, Wako T, Asai A, Horita Y, Taniguchi K, Yano I, Yamamoto S, Onozaki K.

Immun Ageing. 2010 Sep 1;7:12. doi: 10.1186/1742-4933-7-12.

48.

[Accuracy of judgment about others' cooperative behavior: effects of attractiveness and facial expressiveness].

Shinada M, Yamagishi T, Tanida S, Takahashi C, Inukai K, Koizumi M, Yokota K, Mifune N, Takagishi H, Horita Y, Hashimoto H.

Shinrigaku Kenkyu. 2010 Jun;81(2):149-57. Japanese.

49.

[Adaptive foundation of group-based reciprocity].

Horita Y, Yamagishi T.

Shinrigaku Kenkyu. 2010 Jun;81(2):114-22. Japanese.

50.

Biochemical characteristics among Mycobacterium bovis BCG substrains.

Hayashi D, Takii T, Mukai T, Makino M, Yasuda E, Horita Y, Yamamoto R, Fujiwara A, Kanai K, Kondo M, Kawarazaki A, Yano I, Yamamoto S, Onozaki K.

FEMS Microbiol Lett. 2010 May;306(2):103-9. doi: 10.1111/j.1574-6968.2010.01947.x.

Supplemental Content

Loading ...
Support Center